Isaia Barbieri
Isaia Barbieri
Molecular Biotechnology Center, University of Turin
Потвърден имейл адрес: unito.it
Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control
I Barbieri, K Tzelepis, L Pandolfini, J Shi, G Millán-Zambrano, SC Robson, ...
Nature 552 (7683), 126-131, 2017
Role of RNA modifications in cancer
I Barbieri, T Kouzarides
Nature Reviews Cancer 20 (6), 303-322, 2020
METTL1 promotes let-7 MicroRNA processing via m7G methylation
L Pandolfini, I Barbieri, AJ Bannister, A Hendrick, B Andrews, N Webster, ...
Molecular cell 74 (6), 1278-1290. e9, 2019
RNA modifications detection by comparative Nanopore direct RNA sequencing
A Leger, PP Amaral, L Pandolfini, C Capitanchik, F Capraro, V Miano, ...
Nature communications 12 (1), 7198, 2021
Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten
I Barbieri, S Pensa, T Pannellini, E Quaglino, D Maritano, M Demaria, ...
Cancer research 70 (6), 2558-2567, 2010
Bromodomains as therapeutic targets in cancer
I Barbieri, E Cannizzaro, MA Dawson
Briefings in functional genomics 12 (3), 219-230, 2013
BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms
BS Wyspiańska, AJ Bannister, I Barbieri, J Nangalia, A Godfrey, ...
Leukemia 28 (1), 88-97, 2014
The breast cancer oncogene EMSY represses transcription of antimetastatic microRNA miR-31
E Viré, C Curtis, V Davalos, A Git, S Robson, A Villanueva, A Vidal, ...
Molecular cell 53 (5), 806-818, 2014
SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4
K Tzelepis, E De Braekeleer, D Aspris, I Barbieri, MS Vijayabaskar, ...
Nature communications 9 (1), 5378, 2018
IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma
N Prokoph, NA Probst, LC Lee, JM Monahan, JD Matthews, HC Liang, ...
Blood, The Journal of the American Society of Hematology 136 (14), 1657-1669, 2020
Stat3 is required for anchorage‐independent growth and metastasis but not for mammary tumor development downstream of the ErbB‐2 oncogene
I Barbieri, E Quaglino, D Maritano, T Pannellini, L Riera, F Cavallo, ...
Molecular Carcinogenesis: Published in cooperation with the University of …, 2010
MicroRNAs-143 and-145 induce epithelial to mesenchymal transition and modulate the expression of junction proteins
L Avalle, D Incarnato, A Savino, M Gai, F Marino, S Pensa, I Barbieri, ...
Cell Death & Differentiation 24 (10), 1750-1760, 2017
Controlled masking and targeted release of redox-cycling ortho-quinones via a C–C bond-cleaving 1,6-elimination
L Dunsmore, CD Navo, J Becher, EG de Montes, A Guerreiro, E Hoyt, ...
Nature Chemistry 14 (7), 754-765, 2022
Further evidence supporting N7-methylation of guanosine (m7G) in human microRNAs
T Kouzarides, L Pandolfini, I Barbieri, AJ Bannister, B Andrews
Molecular Cell 79 (2), 201-202, 2020
The non-coding epitranscriptome in cancer
V Miano, A Codino, L Pandolfini, I Barbieri
Briefings in functional genomics 20 (2), 94-105, 2021
From tissue invasion to glucose metabolism: the many aspects of signal transducer and activator of transcription 3 pro-oncogenic activities
S Pensa, M Demaria, L Avalle, I Barbieri, A Camporeale, V Poli
Hormone Molecular Biology and Clinical Investigation 10 (1), 217-225, 2012
Roles of non-coding RNAs in tumor growth and development
G Sharma, I Barbieri, G Blandino, V Poli, JA Siddiqui
Frontiers in Oncology 12, 1098315, 2022
Evolution of cancer cell resistance versus intelligent design of epigenetic drugs
I Barbieri, AJ Bannister
Drug Discovery Today: Disease Models 12, 35-39, 2014
STAT3 enhances migration and invasion in mammary tumor cells: a potential role for microRNAs-143 and-145
L Avalle, I Barbieri, S Pensa, P Provero, V Poli
FEBS JOURNAL 278, 195-195, 2011
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–19